We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Digital Workflows at Optum Rx Transform UNH's Patient Experience?
Read MoreHide Full Article
Key Takeaways
UNH's Optum Rx division is automating refill, claim and formulary tasks to streamline pharmacy operations.
AI-driven systems at Optum Rx flag drug risks and improve medication adherence in real time.
UNH posted 19% revenue growth at Optum Rx, fueled by new clients and expanding service relationships.
UnitedHealth Group Incorporated (UNH - Free Report) is doubling down on digital transformation throughout its healthcare ecosystem, with its pharmacy benefits division, Optum Rx, playing a key role in this initiative. In order to give patients a faster, safer and more personalized prescription experience, the company is investing more resources in automated and data-integrated workflows.
At the core of this strategy, Optum Rx is transforming routine administrative tasks like refill authorizations, claim verifications and formulary checks into smart, automated systems. This shift allows pharmacists to spend more time on clinical counselling and engaging with patients rather than doing paperwork. By harnessing predictive analytics and AI-driven platforms, Optum Rx can spot gaps in medication adherence, flag potential drug interactions and suggest optimized therapy options in real time. It also plans to remove the need for reauthorization on certain medications for chronic conditions, which marks another step aimed at making care more straightforward and continuous.
This digital transformation highlights UNH’s commitment to leveraging technology for better healthcare delivery and enhancing patient engagement. In the second quarter of 2025, Optum Rx’s revenues rose 19% year over year, benefited from growth in new clients, expansion in existing client relationships and pharmacy services.
However, the real challenge lies in maintaining the essential human touch throughout the process, making sure that technology enhances the roles of pharmacists and supports patients without replacing the personal guidance that matters most. If UNH can balance between innovation and trust, Optum Rx’s automation model could serve as a blueprint for the broader healthcare system, enhancing patient experiences.
How Are Competitors Faring?
Some of UNH’s major competitors in the AI-enabled healthcare workflows are Elevance Health, Inc. (ELV - Free Report) and Humana Inc. (HUM - Free Report) .
Elevance Health is taking a comprehensive approach by integrating AI across the entire organization. Instead of running isolated programs, Elevance Health is using AI as a strategic asset to reduce costs, enhance operational efficiency and provide clinical and experiential benefits to members and provider partners.
Humana focuses on using AI ethically to improve patient experience, enhance care quality and achieve better health outcomes while ensuring human involvement in any clinical decision-making process. Humana’s CenterWell segment’s revenues rose 11.9% year over year in the second quarter of 2025.
Shares of UNH have declined 26.9% in the year-to-date period compared with the industry’s fall of 21.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 21.48, above the industry average of 16.84. UNH carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2025 earnings is pegged at $16.20 per share, implying a 41.4% drop from the year-ago period.
Image: Bigstock
Can Digital Workflows at Optum Rx Transform UNH's Patient Experience?
Key Takeaways
UnitedHealth Group Incorporated (UNH - Free Report) is doubling down on digital transformation throughout its healthcare ecosystem, with its pharmacy benefits division, Optum Rx, playing a key role in this initiative. In order to give patients a faster, safer and more personalized prescription experience, the company is investing more resources in automated and data-integrated workflows.
At the core of this strategy, Optum Rx is transforming routine administrative tasks like refill authorizations, claim verifications and formulary checks into smart, automated systems. This shift allows pharmacists to spend more time on clinical counselling and engaging with patients rather than doing paperwork. By harnessing predictive analytics and AI-driven platforms, Optum Rx can spot gaps in medication adherence, flag potential drug interactions and suggest optimized therapy options in real time. It also plans to remove the need for reauthorization on certain medications for chronic conditions, which marks another step aimed at making care more straightforward and continuous.
This digital transformation highlights UNH’s commitment to leveraging technology for better healthcare delivery and enhancing patient engagement. In the second quarter of 2025, Optum Rx’s revenues rose 19% year over year, benefited from growth in new clients, expansion in existing client relationships and pharmacy services.
However, the real challenge lies in maintaining the essential human touch throughout the process, making sure that technology enhances the roles of pharmacists and supports patients without replacing the personal guidance that matters most. If UNH can balance between innovation and trust, Optum Rx’s automation model could serve as a blueprint for the broader healthcare system, enhancing patient experiences.
How Are Competitors Faring?
Some of UNH’s major competitors in the AI-enabled healthcare workflows are Elevance Health, Inc. (ELV - Free Report) and Humana Inc. (HUM - Free Report) .
Elevance Health is taking a comprehensive approach by integrating AI across the entire organization. Instead of running isolated programs, Elevance Health is using AI as a strategic asset to reduce costs, enhance operational efficiency and provide clinical and experiential benefits to members and provider partners.
Humana focuses on using AI ethically to improve patient experience, enhance care quality and achieve better health outcomes while ensuring human involvement in any clinical decision-making process. Humana’s CenterWell segment’s revenues rose 11.9% year over year in the second quarter of 2025.
UnitedHealth’s Price Performance, Valuation & Estimates
Shares of UNH have declined 26.9% in the year-to-date period compared with the industry’s fall of 21.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 21.48, above the industry average of 16.84. UNH carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2025 earnings is pegged at $16.20 per share, implying a 41.4% drop from the year-ago period.
Image Source: Zacks Investment Research
UNH stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.